Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The research service provides analysis on regional market penetration and market dynamics. This study also provides a market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the biosimilars market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia as well as Asia-Pacific and Latin America. The study period is 2009–2019, with 2012 as the base year.
Analysis of the Global Biosimilars Market, Opportunity for Global Next-generation Biosimilars Market
Introduction
- Title, Research Team, Table of Contents, List of Exhibits, and Methodology
Executive Summary
- Executive Summary and Key Findings
Market Overview
- Overview
Competitive Playbook
- Market Outlook
Drivers and Restraints for Total Market
- Overview
Forecasts and Trends for Total Market
- Overview
Competitive Analysis
- Overview
Key Companies to Watch
- Overview
Europe Breakdown
- Overview
The United States Breakdown
- Overview
China Breakdown
- Overview
India Breakdown
- Overview
South Korea Breakdown
- Overview
Japan Breakdown
- Overview
Australia Breakdown
- Overview
Latin America Breakdown
- Overview
Brazil Breakdown
- Overview
Mexico Breakdown
- Overview
Argentina Breakdown
- Overview
The Last Word
- Overview
Appendix
- Additional Information
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided along with additional supporting information, such as clinical-trial timelines and results, historical and projected launch timelines, regulatory guidelines for clinical trial design and approval, and global epidemiology by region.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Srinivas Sashidhar |
| WIP Number | M95E-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Biosimilars Market
Analysis of the Global Biosimilars Market
Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth
RELEASE DATE
16-Jan-2014
16-Jan-2014
REGION
Global
Global
Deliverable Type
Market Research
Market Research
Research Code: M95E-01-00-00-00
SKU: LS00093-GL-MR_16934
$10,000.00
In stock
SKU
LS00093-GL-MR_16934